eLife · 13 October 2026 · From issue 51
JAK-STAT pathway heterogeneity governs immunotherapy response in breast cancer
One signaling pathway helps cancer grow but also helps immune cells fight it better.
Jianbo Zhou, Heng Zhang et al.
Integrity screen: passed (3 checks) Checked 16 October 2026. Read the source
The plain-language reading of this paper is in the full issue, for subscribers.
Read the full issue